AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action

Impact · against what's priced in

Aardvark Therapeutics faces significant downside risk due to a securities class action lawsuit alleging an undisclosed FDA clinical hold on its lead drug candidate, ARD-101. BRCB and EMBC are mentioned only in the context of unrelated past lawsuits, making the news immaterial to their current valuations.

AARD−0.80: No priced-in read yet

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action

What matters in this story

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ENCOURAGES YORK SPACE SYSTEMS (YSS) INVESTORS WITH SUBSTANTIAL LOSSES TO CONTACT FIRM PRIOR TO OCT. 30 LEAD PLAINTIFF DEADLINE

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action

What matters in this story

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ENCOURAGES YORK SPACE SYSTEMS (YSS) INVESTORS WITH SUBSTANTIAL LOSSES TO CONTACT FIRM PRIOR TO OCT. 30 LEAD PLAINTIFF DEADLINE

How each ticker is affected

Track these names every morning.

INVESTOR NOTICE: Doximity, Inc. (NYSE: DOCS) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline

Deadline Alert: Netcapital Inc. Stockholders Face December 7, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

YORK SPACE DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important October 30 Deadline in Securities Class Action – YSS

Deadline Alert: Honeywell Aerospace, Inc. Investors Have Until November 23, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action

What matters in this story

Next reads from the same story arc

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ENCOURAGES YORK SPACE SYSTEMS (YSS) INVESTORS WITH SUBSTANTIAL LOSSES TO CONTACT FIRM PRIOR TO OCT. 30 LEAD PLAINTIFF DEADLINE

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action

What matters in this story

Next reads from the same story arc

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, ENCOURAGES YORK SPACE SYSTEMS (YSS) INVESTORS WITH SUBSTANTIAL LOSSES TO CONTACT FIRM PRIOR TO OCT. 30 LEAD PLAINTIFF DEADLINE

How each ticker is affected

Track these names every morning.

INVESTOR NOTICE: Doximity, Inc. (NYSE: DOCS) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline

Deadline Alert: Netcapital Inc. Stockholders Face December 7, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

YORK SPACE DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important October 30 Deadline in Securities Class Action – YSS

Deadline Alert: Honeywell Aerospace, Inc. Investors Have Until November 23, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds